Need help getting care, coverage, or answers?
Get Started
Small White Arrow
See If You Qualify
Small White Arrow

Heart Valve Disease in Older Adults: Treatment Options and Decisions

A senior man on the couch being embraced by his partner from behind.
Key Points
  • Heart valve disease affects more than 10% of adults over 70, with aortic stenosis being the most common and serious type
  • Treatment options range from medications to manage symptoms to surgical repair/replacement and minimally invasive TAVR procedures
  • Age alone shouldn't determine treatment—factors like frailty, quality of life goals, and other health conditions matter more
  • Medicare covers valve procedures including TAVR, but specific criteria must be met and coverage rules can be complex
  • A Solace heart disease advocate can help coordinate your heart team care, navigate Medicare requirements, and ensure you get timely treatment

If you're over 70, there's a one in eight chance you have moderate to severe heart valve disease—even if you don't feel symptoms yet. For those over 75, the numbers climb even higher, with more than 10% of people dealing with significant valve problems that can affect daily life and independence.

The good news? Treatment options have expanded dramatically in recent years. What once required open-heart surgery can now often be fixed through a small incision in your groin. But with more choices comes more complexity—especially when Medicare coverage rules, multiple specialists, and personal health goals all factor into the decision.

This guide walks you through what you need to know about heart valve disease as an older adult, from recognizing symptoms to understanding your treatment options and making decisions that align with your values and lifestyle.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Understanding Heart Valve Disease in Older Adults

How Aging Affects Heart Valves

Your heart has four valves that work like one-way doors, keeping blood flowing in the right direction. Over decades of use—opening and closing about 100,000 times per day—these valves can wear down, stiffen, or develop calcium deposits. This degenerative process is the main cause of valve disease in older adults, quite different from the rheumatic heart disease that was common generations ago.

Think of it like a door hinge that's been used for 70+ years. Eventually, it might not open all the way (stenosis) or might not close tightly (regurgitation). While any valve can be affected, the aortic valve—which controls blood flow from your heart to your body—takes the most wear and tear.

Most Common Types in Seniors

Aortic stenosis is both the most common and most serious valve problem in older adults. When this valve narrows, your heart has to work harder to push blood through. According to the American Heart Association, untreated severe aortic stenosis has a dire prognosis—half of people with symptoms die within two years if left untreated.

Mitral regurgitation comes second, occurring when the valve between your heart's left chambers doesn't close properly, allowing blood to leak backward. This forces your heart to work overtime to maintain blood flow.

Tricuspid regurgitation is increasingly recognized as a problem in older adults, particularly women. While often considered less serious, severe tricuspid regurgitation significantly impacts quality of life and survival.

Recognizing Symptoms vs. "Normal Aging"

Here's the challenge: many people dismiss valve disease symptoms as just "getting older." You might think you're slowing down because of age when actually your heart is struggling to pump blood effectively.

Watch for these warning signs:

  • Getting winded more easily during regular activities
  • Needing to rest more often when walking
  • Feeling lightheaded or dizzy
  • Chest pressure or discomfort
  • Swollen ankles or feet
  • Extreme fatigue that doesn't match your activity level

The danger of the "I'm just getting old" mindset? By the time many people seek help, their valve disease has progressed significantly. As noted by UCHealth cardiac specialists, heart valve disease has an insidious onset—it doesn't happen overnight, making it easy to overlook until it becomes severe.

Diagnosis and Assessment

Initial Evaluation

The journey typically starts with your primary care doctor listening to your heart. A heart murmur—an unusual sound as blood flows through your valves—often provides the first clue. But not all murmurs mean serious problems, and not all valve problems cause murmurs.

The key test is an echocardiogram, essentially an ultrasound of your heart. This painless test shows your valves in action, revealing how well they open and close, and measuring how much blood flows through them. It's the gold standard for diagnosing valve disease and determining its severity.

After age 65, consider asking your doctor these questions at your annual check-up:

  • Should I have my heart valves checked even if I feel fine?
  • Have you heard any unusual sounds when listening to my heart?
  • Could my symptoms be related to my heart valves rather than just aging?

Special Considerations for Older Patients

Evaluating valve disease in older adults comes with unique challenges. Many have limited mobility, making traditional treadmill stress tests difficult or impossible. Other conditions like COPD can mask valve symptoms—you might blame shortness of breath on your lungs when it's actually your heart.

The contribution of multiple health conditions often clouds the picture. Your medical team needs to sort out which symptoms come from valve disease versus other problems. This detective work is crucial because treating the valve disease might improve symptoms you've attributed to other conditions.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Treatment Options: From Conservative to Interventional

Medical Management

Not everyone with valve disease needs immediate surgery. If your valve problem is mild to moderate and you're managing well, medications can help control symptoms and protect your heart. These might include:

Blood pressure medications make it easier for your heart to pump blood through narrowed or leaky valves. Water pills (diuretics) reduce fluid buildup that can cause swelling and breathing problems. Blood thinners prevent clots from forming, particularly important with certain valve conditions.

However, medications can't fix a damaged valve—they're like putting a bandage on a structural problem. Regular monitoring with echocardiograms helps track whether your valve disease is progressing and when it's time to consider other options.

Surgical Valve Repair or Replacement (SAVR)

Traditional open-heart surgery remains an excellent option for many older adults, despite common fears about age. Studies show that even octogenarians and nonagenarians can have excellent outcomes, with surgical treatment often returning survival rates to age-appropriate norms.

During surgical aortic valve replacement (SAVR), surgeons either repair your existing valve or replace it entirely. The choice between mechanical and biological valves matters:

Mechanical valves last longer—potentially a lifetime—but require blood thinners forever. For older adults, the bleeding risk from blood thinners often outweighs the durability benefit.

Biological valves (made from pig, cow, or human tissue) don't require long-term blood thinners but typically need replacement after 10-15 years. For someone in their 70s or 80s, this often means one valve for life.

Recovery from traditional surgery typically takes 4-8 weeks, though minimally invasive surgical approaches can shorten this time. You'll likely spend 5-7 days in the hospital, followed by cardiac rehabilitation to rebuild your strength.

Transcatheter Procedures (TAVR and Others)

Transcatheter aortic valve replacement (TAVR) has revolutionized treatment for older adults with aortic stenosis. Instead of opening your chest, doctors thread a new valve through a catheter inserted in your groin artery, similar to getting a heart catheter.

The compressed replacement valve travels up to your heart, where it's expanded inside your diseased valve. The whole procedure typically takes 1-2 hours, and many patients go home the next day. Compare that to a week in the hospital and months of recovery with traditional surgery.

Recent studies published in the Lancet and New England Journal of Medicine show TAVR isn't just easier—it's often better. Patients have lower mortality rates and fewer strokes compared to surgery, even those at intermediate surgical risk.

For mitral valve problems, the MitraClip offers a similar minimally invasive option. This tiny clip helps the valve close more completely, reducing backward blood flow. While not suitable for everyone, it provides hope for those too high-risk for surgery.

Balloon Valvuloplasty

Sometimes, doctors recommend balloon valvuloplasty—inflating a balloon inside the narrowed valve to stretch it open. Think of it as a temporary fix rather than a cure. The valve often re-narrows within a year, but it can buy time to build strength before definitive treatment or provide symptom relief when other options aren't suitable.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Making Treatment Decisions: Key Factors

The Heart Team Approach

Major valve decisions shouldn't rest on one doctor's opinion. Medicare actually requires a "heart team" approach for TAVR approval, and it's becoming standard practice for all valve decisions. Your team typically includes:

  • Your cardiologist who manages your overall heart health
  • A cardiac surgeon who performs traditional valve surgery
  • An interventional cardiologist who performs TAVR
  • Often a geriatrician who understands aging-related factors

This team reviews your case together, weighing all factors to recommend the best approach for you specifically—not just what's technically possible.

Assessing Surgical Risk vs. Benefits

Traditional surgical risk scores often underestimate risk in elderly patients because they don't capture frailty—that hard-to-define combination of weakness, slowness, and vulnerability that makes recovery harder.

The FRAILTY-AVR study found that a brief frailty assessment predicts outcomes better than age alone. Can you walk across a room without help? Stand from a chair without using your arms? These simple tests reveal more about your surgical readiness than your birthday.

Life expectancy matters too, but not in the way you might think. Even with limited life expectancy, treating valve disease can dramatically improve your remaining years' quality. The question isn't just "How long will I live?" but "How do I want to live?"

Quality of Life Priorities

Every patient values different outcomes. Some prioritize longevity above all else. Others focus on maintaining independence, avoiding nursing home placement, or being well enough to attend a grandchild's wedding.

Recovery time factors heavily into these decisions. If you're 85 and choose traditional surgery, you might spend months recovering—a significant portion of your remaining time. TAVR's quicker recovery might align better with your goals, even if the valve might not last quite as long.

Be honest with your heart team about what matters most to you. There's no wrong answer, only what's right for your situation.

Comorbidities That Affect Decisions

Other health conditions significantly impact treatment decisions and outcomes. Research shows that patients with Alzheimer's and related dementias can still benefit from TAVR, though careful consideration is needed about post-procedure cognitive effects and overall goals of care.

Kidney problems, lung disease, previous strokes, and cancer all factor into the risk-benefit calculation. Sometimes treating the valve disease improves these other conditions; sometimes these conditions make valve treatment too risky.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Medicare Coverage and Access

What Medicare Covers

Medicare Part A covers hospital stays for valve procedures, while Medicare Part B covers doctor services and outpatient procedures. Both SAVR and TAVR are covered when medically necessary, but the definition of "necessary" involves specific criteria.

Original Medicare typically covers 80% of approved costs after you meet your deductible. Medicare Advantage plans may have different cost-sharing structures but must cover what Original Medicare covers.

Medicare's Specific TAVR Requirements

Medicare's coverage for TAVR comes with strict requirements designed to ensure safety and track outcomes:

You must have symptomatic, severe aortic stenosis. "Symptomatic" is key—Medicare won't cover TAVR just because tests show valve narrowing. You need documented symptoms affecting your daily life.

The hospital and heart team must meet volume requirements. Your hospital needs to perform a certain number of procedures annually, ensuring expertise. Not every hospital qualifies, which can mean traveling for treatment.

Participation in a national registry is mandatory. Your outcomes get tracked in a database that helps improve future care. While this benefits future patients, it also means extra paperwork and follow-up requirements.

The valve and delivery system must be FDA-approved. As new devices gain approval, Medicare coverage typically follows, though delays can occur.

Geographic and Access Challenges

Over 90% of TAVR procedures happen in urban teaching hospitals, creating significant access barriers for rural patients. If you live far from a qualified center, factor in:

  • Travel costs for evaluation, procedure, and follow-up
  • Lodging for you and a caregiver
  • The logistics of managing complications far from home

Less than 5% of safety-net hospitals offer TAVR, potentially limiting access for lower-income patients despite Medicare coverage. A Solace advocate can help identify qualified centers and navigate these logistical challenges.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

The Treatment Timeline

From Diagnosis to Treatment

Time matters with valve disease. Research on Medicare beneficiaries shows that delaying TAVR leads to higher healthcare costs and worse outcomes. Every month of delay means potential progression, increased symptoms, and higher risk of complications.

Yet the average patient waits months between diagnosis and treatment. Why? Complex scheduling, insurance requirements, pre-procedure testing, and sometimes simple lack of advocacy for timely care.

Building strength before surgery—called prehabilitation—can improve outcomes. But there's a balance between preparing properly and dangerous delays. Your heart team should provide clear timelines and red flags that would accelerate treatment.

Procedure and Hospital Stay

For TAVR, expect to be in the hospital 1-3 days. The procedure itself takes about an hour, similar to a heart catheterization. You'll be sedated but often not under general anesthesia. Most patients can sit up within hours and walk the next day.

Traditional surgery means 5-7 days in the hospital, including time in intensive care. The surgery takes 3-5 hours under general anesthesia. You'll have a breathing tube initially and gradually increase activity over several days.

Both procedures require someone to drive you home and stay with you initially. Planning for this support is crucial, especially if you live alone.

Post-Procedure Care

Cardiac rehabilitation isn't just exercise—it's a comprehensive program that helps you recover safely, regain strength, and reduce future heart problems. Medicare covers cardiac rehab when prescribed after valve procedures.

Follow-up schedules vary but typically include:

  • One week post-procedure wound check
  • One month echocardiogram to assess valve function
  • Three months, six months, then annual check-ups
  • Blood work to monitor medications

Medication management becomes crucial, especially if you receive a mechanical valve requiring blood thinners. Even with biological valves, you might need blood thinners temporarily.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Special Populations and Considerations

The "Oldest Old" (80+ and 90+)

Age 80, 85, or even 90 doesn't automatically disqualify you from valve treatment. Studies show that octogenarians and nonagenarians can have excellent outcomes, particularly with TAVR. Many return to independent living with dramatically improved quality of life.

The key is selecting appropriate patients—those who are generally robust despite their age, have reasonable cognitive function, and want the treatment. Chronological age matters less than biological age and overall vitality.

Patients with Cognitive Impairment

Having dementia doesn't automatically rule out valve treatment, but it requires careful consideration. Will the patient understand and cooperate with recovery? Can caregivers manage post-procedure needs? What are the realistic goals—extending life or improving comfort?

Recent Medicare data shows that carefully selected dementia patients can benefit from TAVR, with mortality rates improving dramatically over recent years. However, the risk of worsening confusion after any procedure is real and must be weighed.

Those Deemed "Too High Risk"

Sometimes, the heart team determines that intervention risks outweigh benefits. This might occur when:

  • Other conditions limit life expectancy to months
  • Severe frailty makes recovery unlikely
  • Multiple organ failure is present

In these situations, palliative care focuses on comfort and quality of life. Medications can reduce symptoms, oxygen helps breathing, and adjusting activities conserves energy. The goal shifts from fixing the valve to living as well as possible with it.

Two older women smiling outdoors. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Emerging Treatments and Future Directions

The landscape of valve treatment continues evolving rapidly. Newer generation TAVR valves show improved durability and lower complication rates. Devices for tricuspid and mitral valves are expanding options beyond the aortic valve.

Clinical trials offer access to cutting-edge treatments before general approval. Participation provides extra monitoring and follow-up, potentially improving outcomes even for control group patients. Ask your heart team about relevant trials.

The future promises even less invasive approaches, better valve durability, and expanded eligibility criteria. What seems too high-risk today might be routinely treatable tomorrow.

Warning Signs and When to Act

Don't wait for a crisis. Seek immediate medical attention if you experience:

  • Sudden worsening of breathing problems
  • Chest pain that doesn't go away with rest
  • Fainting or near-fainting episodes
  • Rapid weight gain from fluid retention
  • Inability to lie flat due to breathing problems

Remember, with severe aortic stenosis, half of symptomatic patients die within two years without treatment—worse than most cancers. Yet many people wait, hoping things will improve on their own. They won't.

The "wait and see" approach costs lives. If your doctor suggests valve treatment, don't delay. If you're having symptoms but your doctor dismisses them as aging, seek a second opinion. Your life might depend on it.

How a Solace Advocate Can Help

Navigating heart valve disease involves multiple specialists, complex Medicare requirements, and life-changing decisions. A Solace advocate serves as your personal guide through this maze, ensuring nothing falls through the cracks.

Your advocate can coordinate between your cardiologist, cardiac surgeon, and interventional cardiologist, making sure everyone has complete records and communicates effectively. They understand Medicare's coverage requirements for TAVR and can help gather necessary documentation, avoiding delays and denials.

Finding a qualified TAVR center that meets Medicare's volume requirements can be challenging, especially in rural areas. Your advocate researches options, compares outcomes data, and helps arrange logistics for out-of-town treatment if needed.

Before your heart team evaluation, your advocate helps prepare your medical history, organizes relevant test results, and develops questions that address your specific concerns and goals. They can even attend appointments virtually to ensure nothing gets missed.

Managing pre-procedure requirements—from dental clearance to optimization of other health conditions—requires significant coordination. Your advocate tracks these requirements, schedules appointments, and ensures everything is completed timely.

Perhaps most importantly, your advocate helps you weigh treatment options against your personal values and goals. They translate complex medical information into understandable terms, helping you make truly informed decisions.

After your procedure, your advocate continues supporting your recovery, coordinating cardiac rehabilitation, managing follow-up appointments, and ensuring you understand medication changes. They're your consistent point of contact through the entire journey.

Gold background design. Banner text: A healthcare expert on your side. Includes a button: Get an advocate.

Frequently Asked Questions about Heart Valve Disease in Older Adults

At what age is someone "too old" for heart valve surgery?

There's no specific age cutoff for valve procedures. Studies show successful outcomes in patients over 90 when appropriately selected. Your overall health, frailty level, and personal goals matter more than your chronological age. The heart team evaluates each patient individually.

How do I know if I should choose TAVR over traditional surgery?

The choice depends on multiple factors including your surgical risk, anatomy, life expectancy, and personal preferences. Generally, TAVR offers faster recovery with similar or better short-term outcomes, while surgery might provide longer valve durability. Your heart team will recommend the best option, but your values and goals should drive the final decision.

What if my local hospital doesn't offer TAVR?

Medicare covers TAVR at qualified centers, which might require travel. Many patients travel to regional centers for the procedure, returning home after a few days. Consider the logistics carefully—you'll need follow-up care and should have a plan for managing any complications. A Solace advocate can help identify the nearest qualified center and coordinate care between facilities.

Will Medicare cover a second valve procedure if the first one fails?

Yes, Medicare covers repeat procedures when medically necessary. This might involve replacing a biological valve that has worn out, fixing a valve that develops problems, or addressing a different valve. The same coverage criteria apply, and your heart team must document the medical necessity.

How long do replacement valves last in older adults?

Biological valves typically last 10-15 years, though this varies by individual. For someone in their 80s, one valve often lasts the rest of their life. Mechanical valves can last indefinitely but require lifelong blood thinners. TAVR valve durability continues improving, with newer generations showing excellent 5-year results and ongoing studies tracking longer-term outcomes.

This article is for informational purposes only and should not be substituted for professional advice. Information is subject to change. Consult your healthcare provider or a qualified professional for guidance on medical issues, financial concerns, or healthcare benefits.

Related Reading

Learn more about Solace and how a patient advocate can help you.

Takeaways
References
  1. American Heart Association: Understanding Your Heart Valve Treatment Options
  2. British Geriatrics Society: Cardiovascular Care in the Older Adult: Valvular Heart Disease
  3. Centers for Medicare & Medicaid Services: National Coverage Determination for TAVR
  4. Cleveland Clinic: Heart Valve Disease: Symptoms & Treatment
  5. Healthgrades: Medicare Coverage of TAVR
  6. Healthline: Heart Valve Disease in the Elderly
  7. Journal of the American College of Cardiology: Valvular Heart Disease in Patients ≥80 Years of Age
  8. Michigan Medicine: Treating Heart Valve Disease: What Are Your Options?
  9. National Center for Biotechnology Information: Aortic Valve Disease in the Older Adult
  10. National Center for Biotechnology Information: Aortic Valve Replacement Among Patients with Alzheimer's Disease
  11. National Center for Biotechnology Information: Heart Valve Disease in Elderly
  12. National Center for Biotechnology Information: Warning: Medicare May Be Bad for Your Heart
  13. Structural Heart Journal: The Cost of Waiting for TAVR in Medicare Beneficiaries
  14. UCHealth: Heart Valve Disease and Older Adults
Contents
Heading 2 dynamically pulling from the contents of the post
Heading 3 dynamically pulling from the contents of the post